Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Conrad Pfafferott"'
Publikováno v:
Clinical Drug Investigation. 14:146-153
In an observational study in general and internal medicine practices, 5000 patients were treated over a mean of 8 to 9 weeks with fluvastatin. The lipid-lowering effect and tolerability of the preparation were documented. The participating patients h
Autor:
Bernhard Rauch, Rudolf Schiele, Steffen Schneider, Helmut Gohlke, Frank Diller, Martin Gottwik, Gerhard Steinbeck, Tobias Heer, Hugo Katus, Reinhilde Zimmer, Ali Erdogan, Conrad Pfafferott, Jochen Senges for the OMEGA-Study Group
Publikováno v:
Cardiovascular drugs and therapy. 20(5)
During the last decades a large body of data has been accumulated indicating omega-3 fatty acids to exert beneficial effects on the prognosis of patients with cardiovascular disease. Especially, omega-3 fatty acids are regarded to be effective in red
Autor:
Albrecht Vogt, Conrad Pfafferott, Heinz-Jürgen Engel, Ulrich Neumann, Johann Bolte, K. v. Olshausen, H C Mehmel
Publikováno v:
The American journal of cardiology. 88(5)
C stent embolization is an uncommon but potentially hazardous complication of percutaneous transluminal coronary angioplasty (PTCA). Previous small-sized clinical studies reported incidence rates ranging from 0.9% to 8.4%.1–5 In this study we repor
Autor:
Julinda Mehilli, Helmut Schühlen, Martin Fleckenstein, Franz Dotzer, Franz-Josef Neumann, Albert Schömig, Melchior Seyfarth, Josef Dirschinger, Conrad Pfafferott, Adnan Kastrati
Publikováno v:
Scopus-Elsevier
Background —Increased thrombogenicity and smooth muscle cell proliferative response induced by the metal struts compromise the advantages of coronary stenting. The objective of this randomized, multicenter study was to assess whether a reduced stru